Balanced news tone
News Sentiment
VCEL sentiment intelligence
Vericel Corp Ord news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
77/100 classification confidence.
directly relevant articles
high-authority source matches
+7.0% over one week, +15.5% over four weeks, trend inactive, and near fair-value range.
Vericel (VCEL) Stock Could Be 37.3% Undervalued After Earnings Beat And Fund Buying
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Vericel (NASDAQ: VCEL) accounting chief sells 4,855 shares
Vericel's Principal Accounting Officer, Jonathan Siegal, sold a total of 4,855 shares of company common stock in open-market transactions on May 6 and May 7, 2026. These sales, valued at $188,045, were pre-arranged under a Rule 10b5-1 trading plan adopted in December 2025. Follow
- Tone
- Negative 38/100
- Event
- Market update
- Published
- 08 May 2026 20:10
- Source
- Stock Titan
Vericel (VCEL) CFO 10b5-1 sale leaves 21,009 shares held
Vericel Corp's CFO, Mara Joseph Anthony Jr, completed an automatic open-market sale of 5,000 shares of common stock at $40.50 per share on May 7, 2026. This transaction was executed under a pre-arranged Rule 10b5-1 trading plan adopted on December 2, 2025. Following the sale, the
- Tone
- Negative 38/100
- Event
- Market update
- Published
- 08 May 2026 20:10
- Source
- Stock Titan
Vericel (VCEL) Q1 2026 Earnings Transcript
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 08 May 2026 16:31
- Source
- Motley Fool
Vericel Corp 1Q 2026: Revenue $68.43M, EPS ($0.12) — 10-Q Summary
Vericel Corp (VCEL) reported its first-quarter 2026 results, showing revenue of $68.43 million, a 30.1% increase year-over-year from $52.6 million. The company narrowed its net loss to $6.3 million, or diluted EPS of ($0.12), significantly improving from a net loss of $11.25 mill
- Tone
- Positive 70/100
- Event
- Earnings
- Published
- 07 May 2026 20:39
- Source
- TradingView
Vericel Corp reports results for the quarter ended March 31 - Earnings Summary
Vericel Corp has released its earnings summary for the quarter that ended on March 31. The report contains the financial results for the specified period. This news was originally reported by Reuters and published on TradingView.
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 07 May 2026 20:39
- Source
- TradingView
Vericel Shares Rise After Q1 Net Loss Narrows, Revenue Rises; 2026 Revenue Guidance Lifted
- Tone
- Negative 42/100
- Event
- Earnings
- Published
- 07 May 2026 14:15
- Source
- MT Newswires
Vericel Reports First Quarter 2026 Financial Results and Raises Full-Year Financial Guidance
- Tone
- Positive 58/100
- Event
- Earnings
- Published
- 07 May 2026 11:45
- Source
- GlobeNewswire
BARDA burns contract backs NexoBrid growth at Vericel (VCEL)
Vericel Corporation (VCEL) reported strong first-quarter 2026 results with revenue up 30% to $68.4 million, driven by growth in MACI and Epicel sales, while net loss narrowed to $6.3 million. The company reinforced its financial position with $210.6 million in cash and investment
- Tone
- Positive 75/100
- Event
- Earnings
- Published
- 07 May 2026 12:39
- Source
- Stock Titan
Vericel Reports Q1 2026: Revenue Up 30% to $68.4M, Adjusted EBITDA $9.6M
Vericel reported strong first-quarter 2026 results, with total net revenue increasing 30% to $68.4 million and adjusted EBITDA reaching $9.6 million. The company's gross margin was 72%, and it recorded a net loss of $6.3 million, alongside a healthy free cash flow of $15.1 millio
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 07 May 2026 12:09
- Source
- TradingView
Vericel Corporation (VCEL) Reports Q1 Loss, Beats Revenue Estimates
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 07 May 2026 07:00
- Source
- Market source
Vericel Corp (NASDAQ:VCEL) Presents a Compelling Growth and Technical Setup Opportunity
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 05 May 2026 07:00
- Source
- ChartMill
Wall Street Analysts Think Vericel (VCEL) Could Surge 53.42%: Read This Before Placing a Bet
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 04 May 2026 07:00
- Source
- Market source
Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 25 Apr 2026 07:00
- Source
- Market source
Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 Apr 2026 07:00
- Source
- Market source
A Look Back at Biotechnology Stocks’ Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 30 Mar 2026 07:00
- Source
- Market source
Vericel Corp ($VCEL) CEO 2025 Pay Revealed | VCEL Stock News
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 Mar 2026 07:00
- Source
- Quiver Quantitative
What Makes Vericel Corporation (VCEL) an Investment Bet?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Mar 2026 07:00
- Source
- Market source
FDA approves new Vericel cell therapy plant to expand cartilage repair
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Mar 2026 08:00
- Source
- Stock Titan
With EPS Growth And More, Puma Biotechnology (NASDAQ:PBYI) Makes An Interesting Case
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 09 Dec 2025 08:00
- Source
- simplywall.st
There's No Escaping Vericel Corporation's (NASDAQ:VCEL) Muted Revenues Despite A 29% Share Price Rise
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Nov 2025 08:00
- Source
- simplywall.st